| |  Online-Ressource |
|---|
| Verfasst von: | Stallmach, Andreas [VerfasserIn]  |
|---|
| | Giese, Thomas [VerfasserIn] |
|---|
| | Schmidt, Carsten [VerfasserIn] |
|---|
| | Meuer, Stefan [VerfasserIn] |
|---|
| | Zeuzem, Stefan S. [VerfasserIn] |
|---|
| Titel: | Severe anaphylactic reaction to infliximab |
|---|
| Titelzusatz: | successful treatment with adalimumab$dreport of a case |
|---|
| Verf.angabe: | Andreas Stallmach, Thomas Giese, Carsten Schmidt, Stefan C. Meuer, Stefan S. Zeuzem |
|---|
| Jahr: | 2004 |
|---|
| Umfang: | 4 S. |
|---|
| Teil: | volume:16 |
|---|
| | year:2004 |
|---|
| | number:6 |
|---|
| | pages:627-630 |
|---|
| | extent:4 |
|---|
| Fussnoten: | Gesehen am 14.06.2021 |
|---|
| Titel Quelle: | Enthalten in: European journal of gastroenterology & hepatology |
|---|
| Ort Quelle: | Hagerstown, Md. : Lippincott Williams & Wilkins, 1989 |
|---|
| Jahr Quelle: | 2004 |
|---|
| Band/Heft Quelle: | 16(2004), 6, Seite 627-630 |
|---|
| ISSN Quelle: | 1473-5687 |
|---|
| Abstract: | Treatment with the anti-tumour necrosis factor alpha chimeric monoclonal antibody infliximab is highly effective in the treatment of refractory and fistulising Crohn's disease. Infliximab has been tolerated well, with minimal and short-lived adverse effects. The likelihood of severe reactions to infliximab, such as acute and delayed hypersensitivity infusion reactions, is small; nevertheless, if they do occur, they are life-threatening. We report a case of an anaphylaxis-like reaction in a 22-year-old female with long-standing Crohn's disease. The patient was treated successfully with adalimumab, a fully human anti-tumour necrosis factor alpha monoclonal antibody. Follow-up demonstrated mucosal healing and normalisation of elevated pro-inflammatory cytokine transcripts. |
|---|
| DOI: | doi:10.1097/00042737-200406000-00018 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: http://dx.doi.org/10.1097/00042737-200406000-00018 |
|---|
| | DOI: https://doi.org/10.1097/00042737-200406000-00018 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Adalimumab |
|---|
| | Adult |
|---|
| | Anaphylaxis |
|---|
| | Antibodies, Monoclonal |
|---|
| | Antibodies, Monoclonal, Humanized |
|---|
| | Crohn Disease |
|---|
| | Female |
|---|
| | Gastrointestinal Agents |
|---|
| | Humans |
|---|
| | Infliximab |
|---|
| K10plus-PPN: | 1760402990 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Severe anaphylactic reaction to infliximab / Stallmach, Andreas [VerfasserIn]; 2004 (Online-Ressource)
